Market closedNon-fractional
Genus/GNS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Genus
Ticker
GNS
Sector
Healthcare
Trading on
LSE
Industry
Biotechnology
Headquarters
Basingstoke, United Kingdom
Employees
3,500
Website
www.genusplc.com
Genus Metrics
BasicAdvanced
£1.1B
Market cap
34.48
P/E ratio
£0.51
EPS
0.32
Beta
£0.32
Dividend rate
1.83%
Dividend yield
Price and volume
Market cap
£1.1B
Beta
0.32
Dividend rate
£0.32
Financial strength
Current ratio
2.152
Quick ratio
1.304
Long term debt to equity
47.757
Total debt to equity
50.986
Dividend payout ratio (TTM)
62.87%
Interest coverage (TTM)
2.25%
Management effectiveness
Return on assets (TTM)
3.18%
Return on equity (TTM)
5.27%
Valuation
Price to earnings (TTM)
34.479
Price to revenue (TTM)
1.7
Price to book
1.98
Price to tangible book (TTM)
2.88
Price to free cash flow (TTM)
114.454
Dividend yield (TTM)
1.83%
Growth
Revenue change (TTM)
1.62%
Earnings per share change (TTM)
-3.23%
3-year revenue growth (CAGR)
5.92%
3-year earnings per share growth (CAGR)
-7.42%
3-year dividend per share growth (CAGR)
2.17%
What the Analysts think about Genus
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Genus stock.
Genus Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Genus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Genus News
AllArticlesVideos
Genius Group Schedules Full Year 2023 Earnings Call Thursday, May 16, 2024 at 8:30am ET
GlobeNewsWire·2 months ago
Genius Group to Present at the Sidoti Micro Cap Conference
GlobeNewsWire·3 months ago
Genius Group Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
GlobeNewsWire·3 months ago
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Genus stock?
Genus (GNS) has a market cap of £1.1B as of July 27, 2024.
What is the P/E ratio for Genus stock?
The price to earnings (P/E) ratio for Genus (GNS) stock is 34.48 as of July 27, 2024.
Does Genus stock pay dividends?
Yes, the Genus (GNS) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is £0.32 and the yield is 1.83%. Genus has a payout ratio of 62.87% on a trailing twelve-month basis.
When is the next Genus dividend payment date?
The next Genus (GNS) dividend payment date is unconfirmed.
What is the beta indicator for Genus?
Genus (GNS) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Genus stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.